Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2005
11/09/2005EP1592712A2 Anti-dengue virus antibodies, compositions, methods and uses
11/09/2005EP1592686A1 Gyrase inhibitors and uses thereof
11/09/2005EP1592452A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
11/09/2005EP1592448A1 Use of a porphyrin compound for the treatment of skin fungi
11/09/2005EP1592445A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
11/09/2005EP1592442A2 Modified free-living microbes, vaccine compositions and methods of use thereof
11/09/2005EP1592441A2 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1355930B1 A method for identification, isolation and production of antigens to a specific pathogen
11/09/2005EP1309349B1 Pharmaceutical composition and method for the treatment of retroviral infections
11/09/2005EP1295127B1 Inter-alpha-trypsin as a marker for sepsis
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1261259B1 Treatment of infection in animals
11/09/2005EP1255541B1 Aromatic guanylhydrazone for the treatment of resistant viral infections
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1212069B1 Improved topical compositions containing extracellular products of probiotic bacteria and uses thereof
11/09/2005EP1204321B1 Super-active porcine growth hormone releasing hormone analog
11/09/2005EP1154692B1 A method of controlling fungal pathogens, and agents useful for same
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1130964B1 Therapeutic anti-fungal nail preparation
11/09/2005EP1030653B1 Dinitroaniline liposomal formulations and processes for their preparation
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005EP0977874B1 Attenuated salmonella strain used as a vehicle for oral immunization
11/09/2005EP0975227B1 Topical use of probiotic bacillus spores to prevent or control microbial infections
11/09/2005EP0904380B1 Synthetic hiv genes
11/09/2005EP0808330B1 A process for preparing certain aza cyclohexapeptides
11/09/2005EP0792162B1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
11/09/2005EP0750457B1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/09/2005CN1694961A Collectin-complement activating protein chimeras
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694898A HBV precore protein capable of forming particles
11/09/2005CN1694885A Process for the preparation of imipenem
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694736A Medical devices containing rapamycin analogs
11/09/2005CN1694723A Vaccine
11/09/2005CN1694722A A process for the preparation of a non-toxic anthrax vaccine
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/09/2005CN1694709A Antibacterial medicinal composition of enhanced oral absorptivity
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1226305C Protein extracted from perinereis aibuhitensis, its preparation method and use
11/09/2005CN1226302C Ibuprofen triaazole nucleoside ester and preparation method and use thereof
11/09/2005CN1226297C Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
11/09/2005CN1226042C Chinese patent drug for treating hepatitis
11/09/2005CN1226034C Durably antibacterial and deodouring medicine for treating tinea manuum and tinea pedis
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962970 Glycopeptide derivatives and pharmaceutical compositions containing the same
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005US6962916 For therapy of retrovirus infection
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962914 Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds
11/08/2005US6962900 Pharmaceutical being used for treating HIV infection, the composition and uses thereof
11/08/2005US6962710 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/08/2005US6962709 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
11/08/2005CA2297294C Phosphonomethoxymethylpurine/pyrimidine derivatives
11/08/2005CA2269501C Pellets having a core coated with an antifungal and a polymer
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/08/2005CA2247020C Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/08/2005CA2176392C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2149753C Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
11/08/2005CA2123691C Antiviral compositions and method for their use
11/03/2005WO2005103283A1 Novel method of screening
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103065A1 Anthracycline derivatives
11/03/2005WO2005103064A1 Novel sugar chain-supported carbosilane dendrimer
11/03/2005WO2005103049A1 Imidazopyridine compound
11/03/2005WO2005103014A1 2,4-dioxo-5-(2-hydroxy-3,5-dichloro-benzylidene)imino-1,3-pyrimidine salts
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005102360A1 Synergistic composition for inhibiting a human immunodeficiency virus
11/03/2005WO2005102320A1 Medicinal agent for treating viral infections
11/03/2005WO2005102302A1 Medicinal preparation
11/03/2005WO2005102301A2 Hydroxymethylbutyrate compositions and uses thereof
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005WO2004072243A3 Macrocyclic hepatitis c serine protease inhibitors
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245736 Low molecular weight oversulfated polysaccharide
11/03/2005US20050245598 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245552 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005US20050245491 Tetracycline derivatives and methods of use thereof
11/03/2005US20050245469 Crystal forms of azithromycin
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050245466 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
11/03/2005US20050245463 Novel antiretroviral sulfolipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
1 ... 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 ... 1798